^
Association details:
Biomarker:NOTCH1 amplification
Cancer:Colorectal Cancer
Drug:PF‐06293622 (Notch inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer

Excerpt:
As we identified a gain in NOTCH1 gene copy as a prognostic indicator of worse RFS, we investigated the efficacy of a human anti‐Notch1 monoclonal antibody PF‐06293622 on tumor growth in a CRC PDTX model...The four most sensitive CRC explants to the Notch1 antibody harbor a gain in NOTCH1 gene copy number. Using a Fisher's exact test we identified a significant association (p  < 0.006) between a gain in NOTCH1 gene copy number and sensitivity to the Notch1 antibody.
DOI:
10.1002/ijc.29676